Important Safety Information

Last updated: March 1, 2026

About Our Treatments

Everglow Miami provides medically supervised weight loss treatments using compounded GLP-1 medications. All treatments are prescribed by licensed healthcare providers and dispensed by licensed 503B compounding pharmacies.

Compounded Medications Disclaimer

The compounded medications offered by Everglow Miami are not FDA-approved. They are prepared by state-licensed compounding pharmacies in compliance with applicable regulations. Compounded medications may differ from commercially available FDA-approved products in terms of formulation, route of administration, and manufacturing processes.

Semaglutide (Compounded GLP-1)

What is Semaglutide?

Semaglutide is a GLP-1 receptor agonist that helps regulate appetite and blood sugar levels. Our compounded semaglutide is administered as a weekly subcutaneous injection.

Common Side Effects

  • Nausea
  • Vomiting
  • Diarrhea
  • Stomach pain or discomfort
  • Constipation
  • Headache
  • Fatigue
  • Injection site reactions

Serious Side Effects (Seek Immediate Medical Attention)

  • Signs of pancreatitis (severe abdominal pain that may radiate to the back)
  • Gallbladder problems
  • Kidney problems or changes in urination
  • Severe allergic reactions (rash, swelling, difficulty breathing)
  • Changes in vision
  • Rapid heartbeat
  • Depression or suicidal thoughts

Contraindications

Semaglutide should not be used if you have:

  • A personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • A known allergy to semaglutide or any ingredient in the formulation
  • A history of pancreatitis

Tirzepatide (Compounded GLP-1 + GIP)

What is Tirzepatide?

Tirzepatide is a dual GIP/GLP-1 receptor agonist that targets multiple pathways involved in appetite regulation and blood sugar control. Our compounded tirzepatide is administered as a weekly subcutaneous injection.

Common Side Effects

  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Abdominal pain
  • Injection site reactions

Serious Side Effects (Seek Immediate Medical Attention)

  • Signs of pancreatitis
  • Severe allergic reactions
  • Hypoglycemia (low blood sugar), especially if combined with other diabetes medications
  • Kidney injury
  • Gallbladder problems

Contraindications

Tirzepatide should not be used if you have:

  • A personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • A known allergy to tirzepatide or any ingredient in the formulation

General Warnings

  • All patients must complete a medical consultation before starting any treatment.
  • Inform your healthcare provider of all medications, supplements, and medical conditions before beginning treatment.
  • Do not use these medications if you are pregnant, planning to become pregnant, or breastfeeding.
  • Individual results vary. Weight loss outcomes depend on multiple factors including diet, exercise, and adherence to the treatment plan.
  • Report any adverse reactions to your Everglow Miami care team immediately.

Emergency Contact

If you experience a medical emergency, call 911 immediately. For non-emergency questions about your treatment, contact Everglow Miami:

Everglow Miami
Phone: (305) 200-3734
Email: help@everglowmiami.com
Address: 9400 NW 12th Ave, Bay 3, Miami, FL 33150